Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Clin Neurol Neurosurg ; 111(5): 437-41, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19181439

RESUMO

OBJECTIVES: To assess changes in seizure frequency, medication side-effects (especially tremor) and formulation preference after switching patients overnight from immediate-release to extended-release divalproex sodium. METHODS: Prospective evaluation of consecutive adult outpatients at an urban public hospital who were followed for 6 months after switching drug formulations. Seizure frequency was estimated from patient self-reports. Medication side-effects were monitored with a structured interview (tremor, fatigue, GI upset, hair loss), physician exam (nystagmus, tremor), a drawing test (tremor) and a specific 25-item questionnaire assessing the impact of tremor on activities of daily living. RESULTS: Forty-seven patients were included in the study but six patients were either lost to follow-up or had insufficient data. Seizure frequency and side-effect profile did not change significantly after switching drug formulations. However, patients had significant subjective improvement in their tremor with the extended-release formulation as assessed by the 25-item questionnaire (p=0.009 at 3 months and p=0.04 at 6 months); other measures of tremor severity showed no change during the 6-month follow-up period. Most patients (71%) preferred the extended-release formulation. CONCLUSION: Patients with epilepsy can be switched overnight from standard to extended-release divalproex sodium, without significant change in seizure frequency and drug side-effect profile. Most patients prefer the extended-release formulation, in part due to subjective decrease in tremor during daily activities.


Assuntos
Anticonvulsivantes/administração & dosagem , Anticonvulsivantes/uso terapêutico , Epilepsia/tratamento farmacológico , Convulsões/tratamento farmacológico , Ácido Valproico/administração & dosagem , Ácido Valproico/uso terapêutico , Atividades Cotidianas , Adulto , Anticonvulsivantes/efeitos adversos , Peso Corporal/efeitos dos fármacos , Estudos de Coortes , Interpretação Estatística de Dados , Preparações de Ação Retardada , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Satisfação do Paciente , Estudos Prospectivos , Convulsões/etiologia , Tremor/prevenção & controle , Ácido Valproico/efeitos adversos , Adulto Jovem
2.
Arch Phys Med Rehabil ; 88(2): 259-61, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17270527

RESUMO

OBJECTIVE: To determine how often the second lumbrical motor potential is present when the abductor pollicis brevis (APB) motor potential is absent in severe carpal tunnel syndrome (CTS). DESIGN: Prospective study of consecutive patients with severe CTS and an absent motor potential from the APB. SETTING: Single-center public hospital-based electromyography lab. PARTICIPANTS: Patients with a clinical diagnosis of CTS who had an absent median sensory response and an absent median motor response to APB on routine nerve conduction testing. Twenty-two hands of 19 patients were examined. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURE: Presence and distal latency of motor potential to the second lumbrical. RESULTS: The second lumbrical potential was present in 17 hands (77%). The distal motor latency to the second lumbrical was prolonged in all (mean, 9.1ms; normative value, <4.1ms). CONCLUSIONS: Second lumbrical recordings improve localization in many patients with severe CTS when routine median sensory and motor conduction studies produce no potentials.


Assuntos
Síndrome do Túnel Carpal/fisiopatologia , Estimulação Elétrica , Potencial Evocado Motor/fisiologia , Dedos/inervação , Músculo Esquelético/inervação , Eletromiografia , Humanos , Nervo Mediano/fisiopatologia , Condução Nervosa/fisiologia , Estudos Prospectivos , Nervo Ulnar/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA